AH Bio Fund II, L.P. (CIK 1725721) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-29). Recent activity: Buy SCTX (2.1M shares), Buy SCTX (697,650 shares), Buy SCTX (333,333 shares), Sell NAUT (4.6M shares), Sell NAUT (384,026 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-06-04 | Nautilus Biotechnology, Inc. (NAUT) | 10% Owner | Sell | 4.6M | $10.8M |
| 2026-06-04 | Nautilus Biotechnology, Inc. (NAUT) | 10% Owner | Sell | 384,026 | $902,461 |
来源：SEC Form 4 申报文件 · 截至 2026-07-29